R. Cribiu` et al. / Tetrahedron 65 (2009) 2022–2031
2029
4.13. (2,3,6-Tri-O-benzyl-
b-
D-galactofuranosyl)ethene (13b)
Using microwave heating (general procedure 5), diol 9b
and (2,3,5,6-tetra-O-benzyl-
b-D
-galactofuranosyl)ethene (14b)
(496 mg, 0.80 mmol) in acetone (4 mL) was converted with DNBSA
(20 mg, 0.08 mmol) into C-glycoside 16b (319 mg, 78%).
22
Using conventional heating (general procedure 4), diol 8b
(145 mg, 0.26 mmol) in acetone (3 mL) was converted with DNBSA
(6 mg, 0.025 mmol) into C-glycoside 13b (60 mg, 51%).
Using conventional heating (general procedure 4), diol 8b(131 mg,
0.23 mmol) in acetonitrile (2 mL) was converted with DNBSA (6 mg,
0.023 mmol)intoC-glycosides14b (25 mg, 20%)and13b (49 mg, 46%).
Compound 16b, a colourless oil; [
a
]
ꢂ23.9 (c 1.0, CHCl3); nmax
D
3479(br, OH) cmꢂ1; 1H NMR (400 MHz, CDCl3)dH 3.72 (dd, J5,6 6.1 Hz,
J6,6 9.8 Hz, 1H, H-6), 3.84 (dd, J5,6 3.3 Hz, J6,6 9.8 Hz, 1H, H-60), 4.02
(dd, J1,2 3.6 Hz, J2,3 1.0 Hz,1H, H-2), 4.15 (dd, J3,4 3.9 Hz, J4,5 8.0 Hz,1H,
H-4), 4.22 (dd, J2,31.0 Hz, J3,4 3.9 Hz,1H, H-3), 4.39 (ddd, J4,5 8.0 Hz, J5,6
0
0
0
0
6.1 Hz, J5,6 3.3 Hz,1H, H-5), 4.48–4.58 (m, 4H, 2 ꢁ PhCH2), 4.58, 4.63
(ABq, JAB 11.8 Hz, 2H, PhCH2), 4.88 (d, J1,2 3.6 Hz, 1H, H-1), 7.22–7.45
(m, 20H, Ar–H); 13C NMR (100 MHz, CDCl3) dC 68.8 (d, C-5), 71.8, 72.1,
72.4, 73.7 (4ꢁt, C-6, 3ꢁPhCH2), 81.4 (d, C-4), 83.4 (d, C-3), 86.5 (d, C-
1), 89.6 (d, C-2), 126.7, 127.8, 127.8, 127.9, 128.0, 128.0, 128.5, 128.5,
128.6,128.6 (10ꢁd, Ar–CH),137.7,137.8,138.3 (3ꢁs, 3ꢁBn-C),140.7 (s,
Ar–C); m/z (ESþ) 533 (MþNaþ, 100%); HRMS (ESþ) calcd for
C33H34O5Na (MNaþ) 533.2298, found 533.2293. Analysis, found: C,
78.00; H, 6.70. C33H34O5 requires C, 77.62; H, 6.71%.
4.14. (2R,3R,4R,5S,6S)-1,2,3,4,5,6-Hexa-O-benzyl-oct-7-ene-
1,2,3,4,5,6-hexaol (15a)
Diol 7a (500 mg, 0.88 mmol) was dissolved in THF (4 mL), and
BnBr (0.54 mL, 2.11 mmol) and sodium hydride (60% in oil, 100 mg,
2.11 mmol) were added. After 17 h, work-up and column chroma-
tography (pentane/EtOAc, 5:1) gave the fully protected compound
15a (614 mg, 93%) as a colourless oil. 1H NMR (CDCl3, 400 MHz) dH
3.72 (m, 1H), 3.85–3.95 (m, 5H), 4.00 (dd, J 4.5, 7.9 Hz, 1H), 4.17, 4.54
(ABq, JAB 11.8 Hz, 2H, PhCH2), 4.41 (d, J 11.8 Hz, 1H, PhCHH0), 4.50 (s,
2H, PhCH2), 4.59–4.72 (m, 6H, PhCHH0, PhCHH0, 2ꢁPhCH2), 4.80 (d, J
11.3 Hz, 1H, PhCHH0), 4.32–4.39 (m, 2H, H-1b, H-1b0), 5.97 (ddd, J1,1a
4.17. (2,3,6-Tri-O-benzyl-a-D-galactofuranosyl)benzene (17a)
Using conventional heating (general procedure 4), diol 10a
(122 mg, 0.20 mmol) in acetone (2 mL) was converted with DNBSA
(15 mg, 0.06 mmol) into C-glycoside 17a (30 mg, 30%).
0
7.9 Hz, J1a,1b 17.3 Hz, J1a,1b 10.3 Hz, 1H, H-1a), 7.23–7.32 (m, 30H, Ar–
H); 13C NMR (CDCl3, 100 MHz) dC 70.1, 70.2, 72.1, 73.4, 74.1, 74.2, 75.3
(7ꢁt, C-6, 6ꢁPhCH2), 79.3, 79.7, 79.8, 81.2, 81.9 (5ꢁd, C-1, C-2, C-3, C-
4,C-5),119.7(t, C-1b),127.4,127.4,127.5,127.6,127.6,127.7,127.7,127.8,
128.1, 128.1, 128.3, 128.3, 128.3, 128.3, 128.4, 128.4 (16ꢁd, Ar–CH),
136.0 (d, C-1a), 138.6, 138.8, 138.8, 138.9, 139.0, 139.2 (6ꢁs, 6ꢁAr–C);
HRMS (ESþ) calcd for C50H52O6Na (MNaþ) 771.3656, found 771.3654.
Using conventional heating (general procedure 4), diol 10a
(95 mg, 0.154 mmol) in acetonitrile (2 mL) was converted with
DNBSA (4 mg, 0.015 mmol) into C-glycosides 19a (15 mg, 16%) and
17a (49 mg, 63%).
25
Compound 17a, a colourless oil; [
a
]
ꢂ44.3 (c 1.0 CHCl3); nmax
D
3424 (OH) cmꢂ1; 1H NMR (CDCl3, 400 MHz) dH 3.07 (br s,1H, OH-5),
3.55–3.63 (m, 2H, H-6, H-60), 3.70 (d, J1,2 3.2 Hz, 1H, H-2), 3.93 (m,
1H, H-5), 3.97, 4.09 (ABq, JAB 12.0 Hz, 2H, PhCH2), 4.10 (d, J3,4 2.8 Hz,
1H, H-3), 4.18 (dd, J3,4 2.8 Hz, J4,5 3.2 Hz, 1H, H-4), 4.44 (s, 2H,
PhCH2), 4.50 (s, 2H, PhCH2), 5.03 (d, J1,2 3.2 Hz, 1H, H-1), 6.82–6.84
(m, 2H, Ar–H), 7.12–7.34 (m, 18H, Ar–H); 13C NMR (CDCl3, 100 MHz)
dC 70.8 (d, C-5), 71.6 (t, C-6), 71.8, 71.9, 73.4 (3ꢁt, 3ꢁPhCH2), 83.0 (d,
C-1), 83.1 (d, C-2), 84.0 (d, C-4), 84.6 (d, C-3), 127.3, 127.6, 127.7,
127.7, 127.7, 127.7, 127.8, 127.9, 128.0, 128.2, 128.3, 128.5 (12ꢁd, Ar–
CH), 136.2, 137.0, 137.5, 138.2 (4ꢁs, 4ꢁAr–C); HRMS (ESþ) calcd for
C33H34O5Na (MNaþ) 533.2298, found 533.2301.
4.15. (2,3,6-Tri-O-benzyl-a-D-glucofuranosyl)benzene (16a)
Using conventional heating (general procedure 4), diol 9a
(45 mg, 0.073 mmol) in acetone (2 mL) was converted with DNBSA
(2 mg, 0.007 mmol) into C-glycoside 16a (24 mg, 65%).
Using conventional heating (general procedure 4), diol 9a
(129 mg, 0.21 mmol) in acetonitrile (2.5 mL) was converted with
DNBSA (5 mg, 0.021 mmol) into C-glycosides 18a (30 mg, 24%) and
16a (70 mg, 66%).
Using microwave heating (general procedure 5), diol 9a
(237 mg, 0.38 mmol) in acetone (3 mL) was converted with DNBSA
4.18. (2,3,6-Tri-O-benzyl-b-D-galactofuranosyl)benzene (17b)
(10 mg, 0.04 mmol) into C-glycoside 16a (129 mg, 66%).
22
Compound 16a, a colourless oil; [
a]
ꢂ29.3 (c 1.0, CHCl3); nmax
Using conventional heating (general procedure 4), diol 10b
(194 mg, 0.31 mmol) in acetone (3.7 mL) was converted with
DNBSA (8 mg, 0.031 mmol) into C-glycoside 17b (59 mg, 37%).
Using conventional heating (general procedure 4), diol 10b
(134 mg, 0.22 mmol) in acetonitrile (2.6 mL) was converted with
DNBSA (5 mg, 0.022 mmol) into C-glycosides 19b (25 mg, 19%) and
D
3461 (br, OH) cmꢂ1 1H NMR (400 MHz, CDCl3) dH 3.70 (dd, J5,6
;
0
0
0
0
6.0 Hz, J6,6 9.8 Hz,1H, H-6), 3.81 (dd, J5,6 3.1 Hz, J6,6 9.8 Hz,1H, H-6 ),
3.95 (dd, J1,2 3.5 Hz, J2,3 0.9 Hz, 1H, H-2), 4.04, 4.12 (ABq, JAB 12.1 Hz,
0
2H, PhCH2), 4.22 (ddd, J4,5 8.6 Hz, J5,6 6.0 Hz, J5,6 3.1 Hz,1H, H-5), 4.22
(dd, J2,3 0.9 Hz, J3,4 3.7 Hz,1H, H-3), 4.35 (dd, J3,4 3.7 Hz, J4,5 8.6 Hz,1H,
H-4), 4.57 (d, J 11.8 Hz, 1H, PhCHH0), 4.60–4.63 (m, 3H, PhCHH0,
PhCH2), 5.22 (d, J1,2 3.5 Hz, 1H, H-1), 6.90–6.92 (m, 2H, Ar–H), 7.21–
7.39 (m,18H, Ar–H); 13C NMR (100 MHz, CDCl3) dC 68.9 (d, C-5), 72.2,
72.5, 72.8, 73.6 (4ꢁt, C-6, 3ꢁPhCH2), 80.8 (d, C-4), 82.9, 83.1, 83.2
(3ꢁd, C-1, C-2, C-3),127.4,127.6,127.7,127.8,127.8,127.9,128.0,128.1,
128.4, 128.6, 128.7 (11ꢁd, Ar–CH), 137.8, 137.8, 137.9, 138.4, (4ꢁs,
4ꢁAr–C); m/z (ESþ) 1043 (2MþNaþ, 55), 533 (MþNaþ,100%); HRMS
(ESþ) calcd for C33H34O5Na (MNaþ) 533.2298, found 533.2296.
17b (56 mg, 51%).
25
Compound 17b, a colourless oil; [
a
]
ꢂ27.3 (c 1.0 CHCl3); nmax
D
(OH) 3455 cmꢂ1; 1H NMR (CDCl3, 400 MHz) dH 2.70 (br s,1H, OH-5),
3.60–3.63 (m, 2H, H-6, H-60), 4.00 (aq, J 5.3 Hz,1H, H-5), 4.18 (dd, J1,2
5.2 Hz, J2,3 3.6 Hz, 1H, H-2), 4.27–4.33 (m, 2H, H-3, H-4), 4.45, 4.45
(ABq, JAB 11.6 Hz, 2H, PhCH2), 4.52 (s, 2H, PhCH2), 4.55, 4.58 (ABq,
JAB 12.0 Hz, 2H, PhCH2), 5.06 (d, J1,2 5.2 Hz, 1H, H-1), 7.17–7.42 (m,
20H, Ar–H); 13C NMR (CDCl3, 100 MHz) dC 70.5 (d, C-5), 71.5 (t, C-6),
72.0, 72.2, 73.5 (3ꢁt, 3ꢁPhCH2), 83.1 (d, C-4), 84.5 (d, C-3), 84.5 (d,
C-1), 89.7 (d, C-2), 126.3, 127.6, 127.7, 127.7, 127.7, 127.9, 128.4, 128.4,
128.4, 128.5 (10ꢁd, Ar–CH), 137.4, 137.7, 138.0, 140.4 (4ꢁs, 4ꢁAr–C);
HRMS (ESþ) calcd for C33H35O5 (MHþ) 511.2479, found 511.2480;
calcd for C33H34O5Na (MNaþ) 533.2298, found 533.2294.
4.16. (2,3,6-Tri-O-benzyl-b-D-glucofuranosyl)benzene (16b)
Using conventional heating (general procedure 4), diol 9b
(244 mg, 0.40 mmol) in acetone (4.7 mL) was converted with
DNBSA (10 mg, 0.040 mmol) into C-glycoside 16b (130 mg, 65%).
Using conventional heating (general procedure 4), diol 9b
(358 mg, 0.58 mmol) in acetonitrile (8.6 mL) was converted with
DNBSA (14 mg, 0.06 mmol) into C-glycosides 18b (47 mg, 14%) and
16b (211 mg, 71%).
4.19. (2,3,5,6-Tetra-O-benzyl-a-D-glucofuranosyl)benzene (18a)
Alcohol 16a (53 mg, 0.10 mmol) was dissolved in DMF (2 mL), and
the solution was placed under a N2 atmosphere. NaH (60%, 8 mg,